3 months ago
IRWD
AnalystsJason ButlerJason Butler's Stock Forecasts
AnalystsJason Butler
Analyst Ranking
Top 2%
#64 out of 5230 analysts
Average Return
+41.4%
Win Rate
49%82 out of 166
Risk vs Reward
Poor
Good
Jason Butler's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Abivax SaABVX | +1,762.06% | $6.80 | $126.62 | 2025-03-18 - 2026-03-17 | Buy |
Abivax SaABVX | +1,339.19% | $7.12 | $102.47 | 2025-04-30 - 2026-03-27 | Buy |
Abivax SaABVX | +1,147.81% | $8.89 | $110.93 | 2024-12-04 - 2025-12-03 | Buy |
Rezolute IncRZLT | +613.92% | $0.79 | $5.64 | 2023-11-14 - 2024-11-13 | Buy |
Precigen IncPGEN | +376.96% | $0.93 | $4.45 | 2024-12-30 - 2025-12-29 | Buy |
Jason Butler Analyst Color
Get additional color on Jason Butler's coverage of popular stocks
a year ago
TTD
Jason Butler's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Cytokinetics IncCYTK | 18 | Buy | $96.00 | +53.60% | Maintains | a month ago |
Ironwood Pharmaceuticals IncIRWD | 2 | Buy | $8.00 | +161.44% | Upgrades | 3 months ago |
Nasus Pharma LtdNSRX | 1 | Buy | $19.00 | +759.73% | Initiates Coverage On | 3 months ago |
Abivax SaABVX | 5 | Buy | $131.00 | +27.84% | Maintains | 3 months ago |
Prothena Corp Public Ltd CoPRTA | 12 | Buy | $19.00 | +105.18% | Maintains | 4 months ago |
Halozyme Therapeutics IncHALO | 10 | Buy | $92.00 | +49.28% | Maintains | 5 months ago |
Aquestive Therapeutics IncAQST | 8 | Buy | $12.00 | +198.51% | Maintains | 6 months ago |
Rapport Therapeutics IncRAPP | 2 | Buy | $28.00 | +0.57% | Reiterates | 9 months ago |
Acadia Pharmaceuticals IncACAD | 13 | Buy | $37.00 | +78.31% | Reiterates | 9 months ago |
Gh Research PLCGHRS | 5 | Buy | $39.00 | +196.58% | Reiterates | 9 months ago |
Precigen IncPGEN | 11 | Buy | $6.00 | +63.49% | Reiterates | 10 months ago |
Trade Desk IncTTD | 1 | Buy | $100.00 | +369.92% | Maintains | a year ago |
Viridian Therapeutics IncVRDN | 6 | Buy | $38.00 | +38.74% | Maintains | a year ago |
Zevra Therapeutics IncZVRA | 2 | Buy | $18.00 | N/A | Maintains | a year ago |
Esperion Therapeutics IncESPR | 2 | Buy | $4.00 | N/A | Reiterates | a year ago |
Argenx SeARGX | 8 | Buy | $701.00 | N/A | Maintains | a year ago |
Dynavax Technologies CorpDVAX | 1 | Buy | $33.00 | N/A | Maintains | a year ago |
Rezolute IncRZLT | 8 | Buy | $9.00 | N/A | Maintains | a year ago |
Vigil Neuroscience IncVIGL | 4 | Buy | $22.00 | N/A | Reiterates | a year ago |
Syros Pharmaceuticals IncSYRS | 3 | Buy | $4.00 | N/A | Maintains | 2 years ago |
Hookipa Pharma IncHOOK | 3 | Buy | $23.00 | N/A | Maintains | 2 years ago |
Leonabio IncLONA | 5 | Buy | $190.00 | N/A | Reiterates | 2 years ago |
Cormedix IncCRMD | 6 | Buy | $19.00 | N/A | Reiterates | 2 years ago |
Morphosys AgMOR | 3 | Buy | $17.00 | N/A | Reiterates | 2 years ago |
Karuna Therapeutics IncKRTX | 6 | Buy | $318.00 | N/A | Reiterates | 2 years ago |
Gamida Cell LtdGMDAQ | 9 | Buy | $6.00 | N/A | Reiterates | 3 years ago |
Trevena IncTRVN | 2 | Buy | $50.00 | N/A | Reiterates | 3 years ago |
Minerva Neurosciences IncNERV | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Plx Pharma IncPLXPQ | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Applied Molecular Transport IncAMTI | 2 | Buy | $50.00 | N/A | Maintains | 4 years ago |
Marinus Pharmaceuticals IncMRNS | 2 | Buy | $22.00 | N/A | Maintains | 4 years ago |
Quince Therapeutics IncQNCX | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Arena Pharmaceuticals IncARNA | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Enanta Pharmaceuticals IncENTA | 4 | Buy | $116.00 | N/A | Maintains | 4 years ago |
Arbutus Biopharma CorpABUS | 1 | Buy | $9.00 | N/A | Maintains | 4 years ago |
Adamas Pharmaceuticals IncADMS | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Ovid Therapeutics IncOVID | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Pfenex IncPFNX | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Zogenix IncZGNX | 1 | Buy | $56.00 | N/A | Initiates Coverage On | 8 years ago |
Intra Cellular Therapies IncITCI | 1 | Buy | N/A | N/A | Upgrades | 9 years ago |
Forward Pharma AFWPAY | 1 | Hold | N/A | N/A | Downgrades | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.